A detailed history of Four Thought Financial, LLC transactions in Dexcom Inc stock. As of the latest transaction made, Four Thought Financial, LLC holds 4 shares of DXCM stock, worth $303. This represents 0.0% of its overall portfolio holdings.

Number of Shares
4
Previous 4 -0.0%
Holding current value
$303
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022

SELL
$67.99 - $132.89 $11,218 - $21,926
-165 Reduced 97.63%
4 $0
Q1 2022

Apr 29, 2022

BUY
$94.08 - $130.2 $5,080 - $7,030
54 Added 46.96%
169 $86,000
Q3 2021

Nov 12, 2021

SELL
$106.71 - $143.18 $5,122 - $6,872
-48 Reduced 29.45%
115 $62,000
Q2 2021

Nov 12, 2021

BUY
$80.99 - $107.93 $13,201 - $17,592
163 New
163 $69,000

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $29.3B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Four Thought Financial, LLC Portfolio

Follow Four Thought Financial, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Four Thought Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Four Thought Financial, LLC with notifications on news.